Full Text View
Tabular View
No Study Results Posted
Related Studies
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
This study has been terminated.
Study NCT00060515   Information provided by Repligen Corporation
First Received: May 7, 2003   Last Updated: August 4, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mitochondrial Diseases
More general conditions related to this trial
Metabolic Diseases
Sponsors listed in this trial
Repligen Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services